EMA gave a positive opinion about Fexinidazole
We celebrated, together with our colleagues from Drugs for Neglected Diseases initiative - DNDi and partners, the positive opinion given by the European Medicines Agency about Fexinidazole, DNDi’s first “new chemical entity”:
Read more
